Today's Hours: 12:00pm - 8:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Larry K. Golightly, Isaac Teitelbaum, Bonita A. Simendinger, Tyree H, Kiser, Gerard R. Barber, Nancy M. Stolpman.
    Summary: To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types. Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.

    Contents:
    A: Acamprosate to Aztreonam
    B: Bacitracin to Butorphanol
    : Capecitabine to Cycloserine
    D: Dabigatran to Dyphylline
    E: Edetate Calcium Disodium to Exenatide
    F: Famciclovir to Fosfomycin
    H: Hetastarch to Hydroxyurea
    I: Ibandronate to Itraconazole
    K: Kanamycin to Ketorolac
    L: Lacosamide to Lurasidone
    M: Magnesium Citrate to Mycophenolate Mofetil
    N: Nabumetone to Norfloxacin
    O: Ofloxacin to Oxcarbazepine
    P: Paliperidone to Pyridostigmine
    Q: Quinapril to Quinine
    R: Ramipril to Ruxolitinib
    S: Salsalate to Sunitinib
    T: Tadalafil to Trospium
    V: Valacyclovir to Voriconazole
    Z: Zalcitabine to Zonisamide
    Proprietary Name Index.
    Digital Access Springer 2021
  • Article
    Moroz AF, Gaufberg VV, Kharitonova AM.
    Antibiotiki. 1978 Sep;23(9):819-22.
    More severe mastitis on infection with Proteus was shown on a standardized model of experimental lactation mastitis of mice caused by Staphylococcus, Proteus and their mixture. Significant differences in the morphological pictures of the staphylococcal and Proteus mastitis were noted. A pronounced effect was observed with the use of kanamycin in combination with fuzidin in treatment of experimental mastitis of various etiology.
    Digital Access Access Options